azomycin has been researched along with deoxyuridine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hofer, KG; Hofer, MG; Ieracitano, J; McLaughlin, WH | 1 |
de Wilde, PC; Hoogsteen, IJ; Kaanders, JH; Lok, J; Marres, HA; Rijken, PF; van der Kogel, AJ; Wijffels, KI | 1 |
1 review(s) available for azomycin and deoxyuridine
Article | Year |
---|---|
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
2 other study(ies) available for azomycin and deoxyuridine
Article | Year |
---|---|
Radiosensitization of hypoxic tumor cells by simultaneous administration of hyperthermia and nitroimidazoles.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Deoxyuridine; Female; Hyperthermia, Induced; Hypoxia; Leukemia L1210; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Sarcoma | 1977 |
No detectable hypoxia in malignant salivary gland tumors: preliminary results.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Proliferation; Deoxyuridine; Glucose Transporter Type 1; Glucose Transporter Type 2; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Middle Aged; Nitroimidazoles; Salivary Gland Neoplasms | 2009 |